申请人:MERCK SHARP & DOHME CORP.
                            
                            
                                公开号:US09079930B2
                            
                            
                                公开(公告)日:2015-07-14
                            
                            
The present invention relates to substituted pyrimidines useful as HIF prolyl hydroxylase inhibitors to treat anemia and like conditions.
                            本发明涉及替代
嘧啶类化合物,可作为HIF脯
氨酸羟化酶
抑制剂用于治疗贫血和类似疾病。